Explore the latest in vitiligo, including advances in understanding the genetics and management of the disease.
A woman in her 30s with metastatic soft tissue sarcoma being treated with nivolumab presented with diffuse macular cutaneous eruption and pruritus. What is your diagnosis?
This randomized clinical trial evaluates the use of atorvastatin combined with narrowband UV-B therapy vs narrowband UV-B therapy alone in adult patients with active vitiligo.
This case report describes 2 patients who experienced rapid repigmentation of vitiligo-affected skin after tofacitinib plus low-dose, narrowband UV-B therapy.
This randomized clinical trial compares the effects of combined epidermal cell suspension and follicular cell suspension with those of epidermal cell suspension alone in treatment of vitiligo.
This observational pilot study evaluates the efficacy and safety of the 311-nm titanium:sapphire laser in the treatment of vitiligo.
This systematic review and meta-analysis evaluates the treatment responses of vitiligo to phototherapy based on all relevant prospective studies.
This study examines the association of vitiligo with quality of life by location of disease in patients enrolled in an academicc institutional registry.
This cross-sectional study evaluates soluble CD molecules associated with disease activity and progression of vitiligo.
This Clinical Evidence Synopsis summarizes a Cochrane review of clinical trials comparing the effects of monotherapies with combined therapies to treat vitiligo.
This observational study evaluated the appearance of vitiligo as a visible marker of tumor response in a population of patients with melanoma who received treatment with pembrolizumab.
This case report describes effective repigmentation with tofacitinib citrate, a pathogenesis-directed therapy, in a patient with generalized vitiligo.
This randomized clinical trial finds efficacy of cultured epidermal cell suspension and amniotic membrane–cultured epidermal cell grafting in treatment of vitiligo.
This meta-analysis demonstrated that patients with either vitiligo or alopecia areata have significantly increased odds of atopic dermatitis.
Zuo and colleagues set out to determine laboratory markers, transplant-related factors, and other systemic manifestations associated with vitiligo and/or alopecia areata in patients with chronic graft-vs-host disease.
Lim et al evaluate the efficacy and safety of combination therapy for generalized vitiligo consisting of afamelanotide implant and narrowband UV-B (NB–UV-B) phototherapy.
Silverberg and coauthors determine the impact of place of birth and residence on vitiligo extent.
Rishi et al describe the clinical profile, treatment, and outcome in patients with uveal melanoma who subsequently developed cutaneous vitiligo.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: